Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where F. Cartabellotta is active.

Publication


Featured researches published by F. Cartabellotta.


Alimentary Pharmacology & Therapeutics | 2017

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study

Giuseppe Cabibbo; Salvatore Petta; V. Calvaruso; Irene Cacciola; M.R. Cannavò; S. Madonia; M. Distefano; L. Larocca; T. Prestileo; Fabio Tinè; G. Bertino; Lydia Giannitrapani; F. Benanti; Anna Licata; I. Scalisi; Giovanni Mazzola; F. Cartabellotta; Nicola Alessi; Marco Barbara; M. Russello; G. Scifo; Giovanni Squadrito; Giovanni Raimondo; A. Craxì; V. Di Marco; C. Cammà

Data on HCV‐related hepatocellular carcinoma (HCC) early recurrence in patients whose HCC was previously cured, and subsequently treated by direct‐acting antivirals (DAAs), are equivocal.


Digestive and Liver Disease | 2017

Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)

V. Calvaruso; Giuseppe Cabibbo; Irene Cacciola; Salvatore Petta; S. Madonia; Alessandro Bellia; Fabio Tinè; M. Distefano; Lydia Giannitrapani; T. Prestileo; Giovanni Mazzola; A. Davì; L. Larocca; A. Ardiri; A. Digiacomo; Gussio M; L. Guarneri; A. Magro; A. Averna; C. Iacobello; I. Scalisi; F. Cartabellotta; F. Savalli; M. Russello; G. Scifo; Giovanni Squadrito; C. Cammà; Giovanni Raimondo; A. Craxì; V. Di Marco


Journal of Hepatology | 2017

Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals

V. Calvaruso; Giuseppe Cabibbo; Irene Cacciola; Salvatore Petta; S. Madonia; Alessandro Bellia; M.D. Stefano; Lydia Giannitrapani; Fabio Tinè; A. Magro; A. Davì; L. Larocca; A. Ardiri; A. Digiacomo; Gussio M; L. Guarneri; I. Scalisi; Giovanni Mazzola; F. Cartabellotta; F. Savalli; M. Russello; G. Scifo; Giovanni Squadrito; C. Cammà; Giovanni Raimondo; A. Craxì; V. Di Marco


Digestive and Liver Disease | 2017

Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)

Giuseppe Cabibbo; Irene Cacciola; M.R. Cannavò; S. Madonia; V. Calvaruso; Salvatore Petta; M. Distefano; L. Larocca; T. Prestileo; Fabio Tinè; A. Digiacomo; G. Bertino; Lydia Giannitrapani; F. Benanti; A. Davì; Riccardo Volpes; I. Scalisi; C. Iacobello; Giovanni Mazzola; F. Cartabellotta; L. Guarneri; V. Portelli; A. Averna; M. Russello; G. Scifo; Giovanni Squadrito; Giovanni Raimondo; A. Craxì; V. Di Marco; C. Cammà


Journal of Hepatology | 2017

Non-invasive tools to ruling out large varices: RESIST-HCV vs. Baveno VI criteria in a large cohort of patients with HCV cirrhosis

V. Calvaruso; Irene Cacciola; Anna Licata; S. Madonia; R. Benigno; F. Bronte; Salvatore Petta; G. Malizia; G. Bertino; M. Di Stefano; Riccardo Volpes; A. Montineri; A. Di Giacomo; Giuseppe Alaimo; Bruno Cacopardo; L. Guarneri; I. Scalisi; Giovanni Mazzola; F. Cartabellotta; V. Portelli; M. Russello; Giovanni Squadrito; Giovanni Raimondo; A. Craxì; V. Di Marco


Digestive and Liver Disease | 2017

Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry

Irene Cacciola; Salvatore Petta; M. Distefano; M.R. Cannavò; A. Davì; S. Madonia; V. Calvaruso; L. Larocca; F. Di Lorenzo; A. Digiacomo; G. Bertino; Anna Licata; Federica Latteri; F. Benanti; Riccardo Volpes; L. Guarneri; A. Averna; I. Scalisi; C. Iacobello; Piero Colletti; F. Cartabellotta; V. Portelli; M. Russello; G. Scifo; Giovanni Squadrito; Giovanni Raimondo; A. Craxì; V. Di Marco


Digestive and Liver Disease | 2018

Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort

V. Calvaruso; Salvatore Petta; Irene Cacciola; Giuseppe Cabibbo; F. Cartabellotta; A. Di Rosolini; A. Davì; M.R. Cannavò; M. Russello; M. Distefano; G. Scifo; F. Di Lorenzo; T. Prestileo; L. La Rocca; A. Montineri; G. Fiduli; A. Digiacomo; M. Cannizzaro; S. Madonia; Anna Licata; G. Malizia; Giuseppe Alaimo; G. Bertino; Bruno Cacopardo; C. Iacobello; A. Averna; L. Guarneri; I. Scalisi; Giovanni Mazzola; Luigi Mondello


Value in Health | 2017

A Web-Based Hub & Spoke Model For The Management Of HCV Patients And Innovative Treatments: The Resist - HCV Sicily Network Experience

F. Cartabellotta; V. Di Marco; C Dellacasa; A Roncadori; A Covezzoli


Value in Health | 2017

HCV Network Of Sicilian Region: A Best Practice To Monitor Cost And Consequence Of Treatments

F. Cartabellotta; C Aru; F Di Giuseppe; V. Di Marco; D. Integlia; G Pompilio


Journal of Hepatology | 2017

Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

Giuseppe Cabibbo; Irene Cacciola; M.R. Cannavò; S. Madonia; V. Calvaruso; Salvatore Petta; M. Di Stefano; L. Larocca; T. Prestileo; Fabio Tinè; A. Digiacomo; G. Bertino; Lydia Giannitrapani; F. Benanti; A. Davì; Riccardo Volpes; L. Guarneri; A. Averna; I. Scalisi; C. Iacobello; Giovanni Mazzola; F. Cartabellotta; V. Portelli; M. Russello; G. Scifo; Giovanni Squadrito; Giovanni Raimondo; A. Craxì; V. Di Marco; C. Cammà

Collaboration


Dive into the F. Cartabellotta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Craxì

University of Palermo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Davì

University of Palermo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G. Scifo

University of Palermo

View shared research outputs
Researchain Logo
Decentralizing Knowledge